| Literature DB >> 33192376 |
Mohammadreza Radmanesh1, Mahdi Jalili1, Kasia Kozlowska2,3,4.
Abstract
OBJECTIVES: Psychogenic non-epileptic seizures (PNES) have been hypothesized to emerge in the context of neural networks instability. To explore this hypothesis in children, we applied a graph theory approach to examine connectivity in neural networks in the resting-state EEG in 35 children with PNES, 31 children with other functional neurological symptoms (but no PNES), and 75 healthy controls.Entities:
Keywords: EEG; conversion disorder; dissociative attacks; functional brain networks; functional neurological disorder; psychogenic non-epileptic seizures
Year: 2020 PMID: 33192376 PMCID: PMC7477327 DOI: 10.3389/fnhum.2020.00339
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Comparisons between FND and healthy-control group on demographics, IQ, ECG measures, and self-report.
| Age | 13.48 | 13.54 | −0.168 (0.867) |
| Sex | 47/66 girls | 53/75 girls | 0.0051 (0.943) |
| Spot-the-word Test (IQ estimate) | 38.85 | 39.38 | 0.407 (0.685) |
| RMSSD-HRV (arousal estimate) | 55.51 | 68.73 | −2.69 (0.008) |
| Heart rate (arousal estimate) | 85.16 | 75.47 | 5.30 (<0.001) |
| DASS Total Score | 27.83 | 7.57 | 6.08 (<0.001) |
| ELSQ (adverse childhood event load) | 4.36 | 1.39 | 4.41 (<0.001) |
| GAF | 40.22 SD 13.43, range, 11–75 | Assigned an arbitrary value of 81 (lowest value in the healthy range) | −24.66 (<0.001) |
Clinical information about participants with FND obtained from the clinical assessment.
| Illness duration (months) | Mean 4 Range 2 days to 36 months | |
| Total number of FND symptoms | Mean 2.38, median 2 range: 1–7 | |
| Comorbid Pain | 47 | 71.2% |
| Any non-specific somatic symptom | 45 | 68% |
| Comorbid fatigue | 27 | 41% |
| Dizziness | 25 | 38% |
| Breathlessness | 16 | 24% |
| Nausea | 16 | 24% |
| Epilepsy | 2 | 3% |
| Asthma | 2 | 3% |
| Glomerulonephritis | 1 | 1.5% |
| Cerebral palsy | 1 | 1.5% |
| Migraine | 1 | 1.5% |
| Congenital heart disease | 1 | 1.5% |
| Cancer in the kidney (operated on) | 1 | 1.5% |
| Hernia (operated on) | 1 | 1.5% |
| Anxiety disorder (DSM-IV-TR) | 31 | 47% |
| Depressive disorder (DSM-IV-TR) | 10 | 15% |
| Mixed anxiety and depression (DSM-IV-TR) | 8 | 12% |
| Amnesia or other dissociative symptoms | 16 | 24% |
| Total adverse childhood life events (ACEs) elicited on clinical assessment (including maltreatment events) | Mean 5.2 Median 5 Range 1–10 | |
| Family conflict | 41 | 62% |
| Child physical illness | 33 | 50% |
| Bullying | 32 | 49% |
| Maternal mental illness | 27 | 41% |
| Loss via separation from a loved one or a close friend | 24 | 36% |
| Loss via death of a loved one | 22 | 33% |
| Maternal physical illness | 16 | 24% |
| Paternal mental illness | 15 | 23% |
| Paternal physical illness | 13 | 20% |
| Moving house that had been stressful | 13 | 20% |
| Migration | 3 | 5% |
| Maltreatment any | 23 | 16% |
| Exposure to domestic violence | 14 | 21% |
| Physical abuse | 9 | 14% |
| Neglect | 8 | 12% |
| Sexual abuse | 7 | 11% |
| Superior range (120+) | 13 | 19.7% |
| Average range (80–119) | 50 | 75.8% |
| Borderline range (70–79) | 3 | 4.5% |
Comparisons between PNES and FND-other groups on demographics, IQ, ECG measures, self-report, and clinical data.
| Age | Mean 13.77 Median 14.14 Range 9.29–18.16 | Mean 13.15 Median 13.21 Range 7.72–16.15 | 1.182 (0.241) |
| Sex | Boys 11 (31%) Girls 24 (69%) | Boys 8 (26%) Girls 23 (74%) | 0.254 (0.614) |
| Spot-the-Word Test (IQ estimate) | Mean 38.28 | Mean 41.70 | |
| RMSSD-HRV (arousal estimate) | Mean 35.06 | Mean 36.07 | 1.185 (0.241) |
| Heart rate (arousal estimate) | Mean 83.18 | Mean 86.06 | −1.154 (0.253) |
| DASS Total Score | Mean 27.24 | Mean 24.13 | 0.538 (0.593) |
| ELSQ (adverse childhood event load) | Mean 5.00 | Mean 3.67 | 1.152 (0.255) |
| GAF | Mean 39.14 Range 15–65 | Mean 41.45 Range 11–75 | -0.694 (0.490) |
| Illness duration (months) | Mean 4.41 months Range 3 days to 24 months | Mean 5.24 months Range 2 days to 36 months | −0.493 (0.624) |
| Total number of FND symptoms | Mean 2.66, Median 2 Range 1–7 | Mean 2.16 Median 2 Range: 1–5 | 1.432 (0.157) |
| Imaging (CT or MRI) as part of clinical assessment | 27 (77.1%) | 27 (87.1%) | 1.094 (0.295) |
| Number of children taking medication | 4 (1.1%) | 4 (1.3%) | 0.026 (0.871) |
| Comorbid pain | 22 (62%) | 25 (81%) | 2.537 (0.111) |
| Any non-specific somatic symptom (fatigue, dizziness, breathlessness, nausea) | Mean 1.37 Median 1 Range 0–4 | Mean 1.16 Median 1 Range 0–4 | 0.709 (0.481) |
| Children meeting criteria for a mental health diagnosis of anxiety or depression or mixed anxiety/depression | 26 (74.3) | 23 (74.2) | 0.00001 (0.993) |
| Total adverse childhood life events (ACEs) elicited on clinical assessment (including maltreatment events) | Mean 5.40 Median 6 Range 1–10 | Mean 4.97 Median 5 Range 1–10 | 0.754 (0.453) |
| Maltreatment events elicited on clinical assessment | Mean 0.89 Median 1 Range 0–4 | Mean 0.23 Median 0 Range 0–2 | |
| Differences in IQ quotients estimated from school testing and school reports [superior (120+); average (80–119); borderline (70–79)] | Superior 6 (17%) Average 27 (77%) Borderline 2 (6%) | Superior 7 (23%) Average 23 (74%) Borderline 1 (3%) | 0.500 (0.783) |
FIGURE 1This figure depicts the functional neurological symptoms experienced by the 66 children with FND who were included in the analysis. Thirty five children and adolescents presented with psychogenic non-epileptic seizures (PNES) as part of their presentation (top dotted circle). PNES presented as follows: paroxysmal limb movements (n = 9); syncope-like events (n = 7); paroxysmal limb movements and syncope-like events (n = 6); paroxysmal limb movement and spacing-out events (n = 5); paroxysmal limb movements, syncope-like events, and spacing-out events (n = 3); syncope-like events and spacing out (n = 3); paroxysmal limb movements and incontinence (n = 1); and syncope-like, spacing-out events, choking sensation, and paresthesia in the fingers (n = 1). Thirty- one children presented with other functional neurological symptoms, but no PNES. Across both groups—PNES and FND-other—other functional neurological symptoms were mixed and occurred in various combinations: leg weakness/paralysis, loss of speech (negative motor symptoms); functional tics/tremor/jerking, dystonia in a limb, cough, vomiting/rumination, astasia-abasia (positive motor symptoms); and leg anesthesia/paresthesia, loss of vision, loss of hearing, globus sensation (sensory symptoms).
FIGURE 2Global efficiency as a function of network density for patients with PNES, patients with other FND symptoms and controls. The plots show the global efficiency of functional brain networks as a function of density in the PNES group (black lines), FND-other group (black dash lines) and controls (cyan lines) for different frequency bands from 0.05 to 0.3. Circle and diamond shapes indicate the densities that the differences in PNES/FND-other vs. controls is less than P < 0.05 (Wilcoxon’s ranksum test; uncorrected for multiple comparison).
FIGURE 3Local efficiency as a function of network density for patients with PNES, patients with other FND symptoms and controls. The plots show the local efficiency of functional brain networks as a function of density in the PNES group (black lines), FND-other group (black dash lines) and controls (cyan lines) for different frequency bands. Other designations are as Figure 2.
FIGURE 4Modularity index as a function of network density for patients with PNES, patients with other FND symptoms and controls. The plots show the modularity of functional brain networks as a function of density in the PNES group (black lines), FND-other group (black dash lines) and controls (cyan lines) for different frequency bands. Other designations are as Figure 2.
FIGURE 5Scatterplots for correlations between the graph theory metrics and the RMSSD-HRV obtained for EEG beta and gamma bands in children with PNES. The network density, correlation value and p-value for each plot has been indicated by D, ρ, and pVal, respectively.